Exploring prognostic factors in patients achieving PCR after neoadjuvant therapy for triple-negative breast cancer: A retrospective study based on SEER data

被引：0
|
作者：
Wenjie, L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Breast Surg, Sch Med, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.169
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
38P
引用
收藏
页码：S1480 / S1480
页数：1
相关论文
共 50 条
  • [31] The prognostic impact of age in patients with triple-negative breast cancer
    Cornelia Liedtke
    K. R. Hess
    T. Karn
    A. Rody
    L. Kiesel
    G. N. Hortobagyi
    L. Pusztai
    A. M. Gonzalez-Angulo
    Breast Cancer Research and Treatment, 2013, 138 : 591 - 599
  • [32] Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy
    Asaga, Sota
    Kinoshita, Takayuki
    Hojo, Takashi
    Suzuki, Junko
    Jimbo, Kenjiro
    Tsuda, Hitoshi
    CLINICAL BREAST CANCER, 2013, 13 (01) : 40 - 46
  • [33] Development of prognostic nomograms using institutional data for patients with triple-negative breast cancer
    Zhou, Jie-Yu
    Lu, Kang-Kang
    Fu, Wei-Da
    Shi, Hao
    Gu, Jun-Wei
    Lu, Yi-Qiao
    Guo, Gui-Long
    FUTURE ONCOLOGY, 2021, 17 (36) : 5077 - 5091
  • [34] Phase II study of camrelizumab plus chemotherapy as neoadjuvant therapy in patients with early triple-negative breast cancer
    Wang, Y.
    Liu, Y.
    Zhu, S.
    Bi, X.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S616 - S616
  • [35] Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy
    Yam, C.
    Raghavendra, A.
    Hess, K. R.
    Adrada, B. E.
    Candelaria, R. P.
    Damodaran, S.
    Gilcrease, M. Z.
    Helgason, T.
    Hortobagyi, G. N.
    Huo, L.
    Layman, R. M.
    Lim, B.
    Litton, J. K.
    Mittendorf, E. A.
    Murthy, R. K.
    Piwnica-Worms, H.
    Rauch, G. M.
    Santiago, L.
    Symmans, F.
    Thompson, A. M.
    Tripathy, D.
    Ueno, N. T.
    Valero, V.
    Barcenas, C. H.
    Moulder, S. L.
    Yang, W.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
    Liedtke, Cornelia
    Mazouni, Chafika
    Hess, Kenneth R.
    Andre, Fabrice
    Tordai, Attila
    Mejia, Jaime A.
    Symmans, W. Fraser
    Gonzalez-Angulo, Ana M.
    Hennessy, Bryan
    Green, Marjorie
    Cristofanilli, Massimo
    Hortobagyi, Gabriel N.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (08) : 1275 - 1281
  • [37] Update of survival and prognostic factors of triple-negative breast cancer in Thailand
    Rojratsirikul, C.
    Jaisthaporn, K.
    Pornpraserthsuk, P.
    Sinthusake, T.
    Cheirsilpa, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 312 - 312
  • [38] Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
    Lin, Yuxiang
    Lin, E.
    Li, Yan
    Chen, Xiaobin
    Chen, Minyan
    Huang, Jun
    Guo, Wenhui
    Chen, Lili
    Wu, Long
    Zhang, Xiang
    Zhang, Wenzhe
    Jin, Xuan
    Zhang, Jie
    Fu, Fangmeng
    Wang, Chuan
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [39] Transcriptomic changes in invasive residual cancer after neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Orozco, Javier
    Manughian-Peter, Ayla
    Gago, Francisco
    Chang, Grace
    Grumley, Janie
    Marzese, Diego
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 23 - 24
  • [40] Clinical Implications of Transcriptomic Changes After Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
    Orozco, Javier I. J.
    Grumley, Janie G.
    Matsuba, Chikako
    Manughian-Peter, Ayla O.
    Chang, Shu-Ching
    Chang, Grace
    Gago, Francisco E.
    Salomon, Matthew P.
    Marzese, Diego M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3185 - 3193
12345